Ketamine/propofol admixture (ketofol) at induction in the critically ill against etomidate (KEEP PACE trial): study protocol for a randomized controlled trial

Nathan J Smischney, Sumedh S Hoskote, Alice Gallo de Moraes, Carlos J Racedo Africano, Perliveh M Carrera, Rudy Tedja, Jasleen K Pannu, Elizabeth C Hassebroek, Dereddi Raja S Reddy, Richard F Hinds, Lokendra Thakur, Nathan J Smischney, Sumedh S Hoskote, Alice Gallo de Moraes, Carlos J Racedo Africano, Perliveh M Carrera, Rudy Tedja, Jasleen K Pannu, Elizabeth C Hassebroek, Dereddi Raja S Reddy, Richard F Hinds, Lokendra Thakur

Abstract

Background: Endotracheal intubation (ETI) is commonly performed as a life-saving procedure in the intensive care unit (ICU). It is often associated with significant hemodynamic perturbations and can severely impact the outcome of ICU patients. Etomidate is often chosen by many critical care providers for the patients who are hypotensive because of its superior hemodynamic profile compared to other induction medications. However, recent evidence has raised concerns about the increased incidence of adrenal insufficiency and mortality associated with etomidate use. A combination of ketamine and propofol (known as ketofol) has been studied in various settings as an alternative induction agent. In recent years, studies have shown that this combination may provide adequate sedation while maintaining hemodynamic stability, based on the balancing of the hemodynamic effects of these two individual agents. We hypothesized that ketofol may offer a valuable alternative to etomidate in critically ill patients with or without hemodynamic instability.

Methods/design: A randomized controlled parallel-group clinical trial of adult critically ill patients admitted to either a medical or surgical ICU at Mayo Clinic in Rochester, MN will be conducted. As part of planned emergency research, informed consent will be waived after appropriate community consultation and notification. Patients undergoing urgent or emergent ETI will receive either etomidate or a 1:1 admixture of ketamine and propofol (ketofol). The primary outcome will be hemodynamic instability during the first 15 minutes following drug administration. Secondary outcomes will include ICU length of stay, mortality, adrenal function, ventilator-free days and vasoactive medication use, among others. The planned sample size is 160 total patients.

Discussion: The overall goal of this trial is to assess the hemodynamic consequences of a ketamine-propofol combination used in critically ill patients undergoing urgent or emergent ETI compared to etomidate, a medication with an established hemodynamic profile. The trial will address a crucial gap in the literature regarding the optimal induction agent for ETI in patients that may have potential or established hemodynamic instability. Greater experience with planned emergency research will, hopefully, pave the way for future prospective randomized clinical trials in the critically ill population.

Trial registration: Clinicaltrials.gov: NCT02105415. 31 March 2014.

References

    1. Griesdale DE, Bosma TL, Kurth T, Isac G, Chittock DR. Complications of endotracheal intubation in the critically ill. Intensive Care Med. 2008;34:1835–42. doi: 10.1007/s00134-008-1205-6.
    1. Walz JM, Zayaruzny M, Heard SO. Airway management in critical illness. Chest. 2007;131:608–20. doi: 10.1378/chest.06-2120.
    1. Divatia JV, Khan PU, Myatra SN. Tracheal intubation in the ICU: Life saving or life threatening? Indian J Anaesth. 2011;55:470–5. doi: 10.4103/0019-5049.89872.
    1. Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med. 2011;37:901–10. doi: 10.1007/s00134-011-2160-1.
    1. Bloomfield R, Noble DW. Etomidate, pharmacological adrenalectomy and the critically ill: a matter of vital importance. Crit Care. 2006;10:161. doi: 10.1186/cc5020.
    1. Cherfan AJ, Tamim HM, AlJumah A, Rishu AH, Al-Abdulkareem A, Al Knawy BA, et al. Etomidate and mortality in cirrhotic patients with septic shock. BMC Clin Pharmacol. 2011;11:22. doi: 10.1186/1472-6904-11-22.
    1. Cotton BA, Guillamondegui OD, Fleming SB, Carpenter RO, Patel SH, Morris JA, Jr, et al. Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients. Arch Surg. 2008;143:62–7. doi: 10.1001/archsurg.143.1.62.
    1. Hildreth AN, Mejia VA, Maxwell RA, Smith PW, Dart BW, Barker DE. Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. J Trauma. 2008;65:573–9. doi: 10.1097/TA.0b013e31818255e8.
    1. Sunshine JE, Deem S, Weiss NS, Yanez ND, Daniel S, Keech K, et al. Etomidate, adrenal function, and mortality in critically ill patients. Respir Care. 2013;58:639–46.
    1. Warner KJ, Cuschieri J, Jurkovich GJ, Bulger EM. Single-dose etomidate for rapid sequence intubation may impact outcome after severe injury. J Trauma. 2009;67:45–50. doi: 10.1097/TA.0b013e3181a92a70.
    1. Chen WH, Lee CY, Hung KC, Yeh FC, Tseng CC, Shiau JM. The direct cardiac effect of propofol on intact isolated rabbit heart. Acta Anaesthesiol Taiwan. 2006;44:19–23.
    1. Smischney NJ, Beach ML, Loftus RW, Dodds TM, Koff MD. Ketamine/propofol admixture (ketofol) is associated with improved hemodynamics as an induction agent: a randomized, controlled trial. J Trauma Acute Care Surg. 2012;73:94–101. doi: 10.1097/TA.0b013e318250cdb8.
    1. Yang HS, Song BG, Kim JY, Kim SN, Kim TY. Impact of propofol anesthesia induction on cardiac function in low-risk patients as measured by intraoperative Doppler tissue imaging. J Am Soc Echocardiogr. 2013;26:727–35. doi: 10.1016/j.echo.2013.03.016.
    1. Jabre P, Combes X, Lapostolle F, Dhaouadi M, Ricard-Hibon A, Vivien B, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet. 2009;374:293–300. doi: 10.1016/S0140-6736(09)60949-1.
    1. Kreter B. Ketamine as an anesthetic agent for interventional radiology. Semin Int Radiol. 1987;4:183–8. doi: 10.1055/s-2008-1076005.
    1. Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth. 1989;36:186–97. doi: 10.1007/BF03011442.
    1. White PF. Clinical pharmacology of intravenous induction drugs. Int Anesthesiol Clin. 1988;26:98–104. doi: 10.1097/00004311-198802620-00003.
    1. White PF, Way WL, Trevor AJ. Ketamine–its pharmacology and therapeutic uses. Anesthesiology. 1982;56:119–36. doi: 10.1097/00000542-198202000-00007.
    1. Jakobsen CJ, Torp P, Vester AE, Folkersen L, Thougaard A, Sloth E. Ketamine reduce left ventricular systolic and diastolic function in patients with ischaemic heart disease. Acta Anaesthesiol Scand. 2010;54:1137–44. doi: 10.1111/j.1399-6576.2010.02283.x.
    1. Reves JG, Glass PSA, Lubarsky DA, McEvoy MD, Martinez-Ruiz R. Intravenous anesthetics. In: Miller RD, LA Eriksson LIF, Wiener-Kronish JP, Young WL, editors. Miller’s anesthesia. 7. Philadelphia: Churchill Livingstone; 2010. pp. 719–68.
    1. Mort TC. Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts. Anesth Analg. 2004;99:607–13. doi: 10.1213/01.ANE.0000122825.04923.15.
    1. Mort TC. The incidence and risk factors for cardiac arrest during emergency tracheal intubation: a justification for incorporating the ASA Guidelines in the remote location. J Clin Anesth. 2004;16:508–16. doi: 10.1016/j.jclinane.2004.01.007.
    1. Dundee JW, Bovill JG, Clarke RS, Pandit SK. Problems with ketamine in adults. Anaesthesia. 1971;26:86. doi: 10.1111/j.1365-2044.1971.tb04721.x.
    1. Chen J, Li W, Hu X, Wang D. Emergence agitation after cataract surgery in children: a comparison of midazolam, propofol and ketamine. Paediatr Anaesth. 2010;20:873–9. doi: 10.1111/j.1460-9592.2010.03375.x.
    1. Gruber RP, Morley B. Ketamine-assisted intravenous sedation with midazolam: benefits and potential problems. Plast Reconstr Surg. 1999;104:1823–5. doi: 10.1097/00006534-199911000-00034.
    1. Levanen J, Makela ML, Scheinin H. Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. Anesthesiology. 1995;82:1117–25. doi: 10.1097/00000542-199505000-00005.
    1. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298:2644–53. doi: 10.1001/jama.298.22.2644.
    1. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301:489–99. doi: 10.1001/jama.2009.56.
    1. Andolfatto G, Willman E. A prospective case series of single-syringe ketamine-propofol (Ketofol) for emergency department procedural sedation and analgesia in adults. Acad Emerg Med. 2011;18:237–45. doi: 10.1111/j.1553-2712.2011.01010.x.
    1. Dal T, Sazak H, Tunc M, Sahin S, Yilmaz A. A comparison of ketamine-midazolam and ketamine-propofol combinations used for sedation in the endobronchial ultrasound-guided transbronchial needle aspiration: a prospective, single-blind, randomized study. J Thorac Dis. 2014;6:742–51.
    1. Goh PK, Chiu CL, Wang CY, Chan YK, Loo PL. Randomized double-blind comparison of ketamine-propofol, fentanyl-propofol and propofol-saline on haemodynamics and laryngeal mask airway insertion conditions. Anaesth Intensive Care. 2005;33:223–8.
    1. Nejati A, Moharari RS, Ashraf H, Labaf A, Golshani K. Ketamine/propofol versus midazolam/fentanyl for procedural sedation and analgesia in the emergency department: a randomized, prospective, double-blind trial. Acad Emerg Med. 2011;18:800–6. doi: 10.1111/j.1553-2712.2011.01133.x.
    1. Gallo de Moraes A, Racedo Africano CJ, Hoskote SS, Reddy DRS, Tedja R, Thakur L, et al. Case series of ketamine-propofol admixture, “Ketofol”, for endotracheal intubations in the critically ill. Am J Case Rep. 2015;16:81–6. doi: 10.12659/AJCR.892424.
    1. Dewhirst E, Frazier WJ, Leder M, Fraser DD, Tobias JD. Cardiac arrest following ketamine administration for rapid sequence intubation. J Intensive Care Med. 2013;28:375–9. doi: 10.1177/0885066612448732.
    1. Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors. Exception from Informed Consent Requirements for Emergency Research. . Accessed December 1st, 2012.
    1. Keep pace clinical trial instructional video. . Accessed June 1st, 2014.
    1. Ketamine / Propofol Admixture “Ketofol” at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial. . Accessed March 31st, 2014.
    1. Hui TW, Short TG, Hong W, Suen T, Gin T, Plummer J. Additive interactions between propofol and ketamine when used for anesthesia induction in female patients. Anesthesiology. 1995;82:641–8. doi: 10.1097/00000542-199503000-00005.
    1. Johnson KB, Egan TD, Kern SE, McJames SW, Cluff ML, Pace NL. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology. 2004;101:647–59. doi: 10.1097/00000542-200409000-00013.
    1. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937–49. doi: 10.1097/CCM.0b013e31817603ba.
    1. Herasevich V, Pickering BW, Dong Y, Peters SG, Gajic O. Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. Mayo Clin Proc. 2010;85:247–54. doi: 10.4065/mcp.2009.0479.
    1. Heffner AC, Swords D, Kline JA, Jones AE. Frequency and significance of post-intubation hypotension during emergency airway management. J Crit Care. 2012;27:417. doi: 10.1016/j.jcrc.2012.04.022.
    1. Heffner AC, Swords DS, Nussbaum ML, Kline JA, Jones AE. Predictors of the complication of postintubation hypotension during emergency airway management. J Crit Care. 2012;27:587–93. doi: 10.1016/j.jcrc.2012.04.022.
    1. Guidance for Industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials; availability. . Accessed December 1st, 2012.
    1. The use of the WHO-UMC system for standardised case causality assessment. . Accessed December 1st, 2012.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren